F2G is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat life-threatening invasive fungal infections. F2G has discovered and developed a completely new class of antifungal agents called the orotomides. The orotomides have a distinct mechanism of action, selectively targeting fungal dihydroorotate dehydrogenase (DHODH), a key enzyme in the de novo pyrimidine biosynthesis pathway. This differentiates the orotomides from the currently marketed antifungal agents. Olorofim (formerly F901318) is F2G’s leading candidate from this class and has fungicidal activity against a broad range of mould infections including a variety of rare and resistant moulds that cause life-threatening infections for which current therapies have limitations or are ineffective. F2G has completed enrollment in a global Phase 3 trial (“OASIS”) to compare treatment with olorofim versus liposomal amphotericin B followed by standard of care (SOC) in patients with invasive fungal disease caused by proven Invasive Aspergillus or probable lower respiratory tract disease by Aspergillus species. Olorofim has received orphan drug status from the European Medicines Agency and orphan drug status, Qualified Infectious Disease Product (QIDP) designation and Breakthrough Therapy designation from FDA. F2G is headquartered in the UK with subsidiaries in the US and Austria.
Rating Reviews
Rating is calculated based on
2
reviews and is evolving.
Pros: Working at F2G has been a great experience, especially concerning the flexibility offered in my role. As the Senior Director, Global Head of Information Technology, I've been able to manage global responsibilities effectively from Princeton, NJ, with excellent remote work options, allowing a true work-life balance. The collaborative culture among the IT team and across departments in this biotech company is fantastic, fostering strong teamwork. Ample opportunities exist for learning new
Cons: While the work flexibility is a major plus, sometimes the workload during peak project phases can be quite demanding, requiring careful prioritization. Communication across different global time zones, which is common in a global role within a biotech company, occasionally has its challenges, leading to minor delays in decision-making for some IT initiatives. The approval processes for new solutions can sometimes feel a bit drawn out.
Advice to Management: Continue fostering the strong culture of work flexibility, especially for global roles like the Senior Director, Global Head of Information Technology. Streamlining cross-functional approval processes would enhance efficiency, allowing the IT department to implement critical initiatives more
Show more
Pros: Working at F2G offered a unique chance to contribute to a vital mission within the biotech industry. The cross-functional collaboration was strong, especially within my IT leadership team, and I felt genuinely supported in implementing global technology strategies. The focus on scientific innovation meant that IT was truly seen as an enabler, not just a cost center. We had decent work flexibility for a global role, which was crucial for managing teams across different time zones. The company
Cons: While overall job security was solid, the nature of a growing biotechnology company means priorities can shift quickly, which sometimes impacted long-term IT project planning and resource allocation. The approval processes for major technology investments could occasionally be cumbersome, leading to delays. Communication between the global offices sometimes required extra effort to ensure alignment. Workload could be high during critical clinical trial phases or new product launches, common in
Advice to Management: Continue to invest in robust IT infrastructure and strategic planning to support global operations. Streamlining some of the cross-departmental approval workflows would significantly increase efficiency for key initiatives. Ensuring consistent and transparent communication across all international
Show more
What is the typical work-life balance like for software engineers at F2G, especially when working on critical projects?
Software engineers at F2G generally experience a good work-life balance, though it can shift during intense project phases. The company encourages team members to manage their time effectively, and overtime is typically compensated or managed with time off in lieu.
Does F2G offer remote or hybrid work options for their software engineering roles in the UK?
F2G generally operates with a hybrid model, allowing employees to work from home a couple of days a week. While some roles might offer more flexibility, it's common for software engineers in their London office to blend remote work with in-office collaboration.
We
UK
